Caldera Medical Acquires Atlantic Therapeutics to Expand Portfolio in Women’s Health

7 September 2023

Caldera Medical, a prominent women's health medical device company specializing in cutting-edge solutions for Stress Urinary Incontinence, Pelvic Organ Prolapse, Polyps, and Fibroids, has announced the successful completion of its acquisition of Atlantic Therapeutics, an Ireland-based provider of non-invasive pelvic floor strengthening and nerve stimulation solutions for women. This strategic acquisition enhances Caldera Medical's expanding product portfolio and reinforces its commitment to enhancing the quality of life for women.

With the addition of Atlantic Therapeutics to its fold, Caldera Medical gains access to the Innovo product family, a leading non-invasive solution cleared by the FDA, positioned as a primary treatment option for women dealing with stress urinary incontinence. Caldera Medical intends to maintain a European headquarters and innovation center in Galway, Ireland, underscoring its dedication to fostering innovation and excellence in the field.

Bryon Merade, CEO of Caldera Medical, expressed enthusiasm about the acquisition, stating, "We are delighted to bring Atlantic Therapeutics into our fold and expand the global reach of the Innovo product line, which has been rapidly gaining traction. This acquisition seamlessly aligns with our mission and enables us to offer an even more comprehensive array of healthcare solutions to both providers and patients."

Susan Trent, CEO of Atlantic Therapeutics, commented on the merger, saying, "Since our inception, the Atlantic Therapeutics team has showcased the immense potential of the Innovo technology, supported by robust clinical data. This technology is ideally positioned to provide relief to millions of women worldwide grappling with the daily challenges of SUI. Caldera Medical's expertise in maximizing this potential represents the perfect progression. I am thrilled to witness Innovo flourish under Caldera Medical's stewardship and extend my gratitude to Bryon and the team for their unwavering commitment to women's health."

 

Source: businesswire.com